Medicare Enrolled
Dr. Mussa Banisadre, MD
Hematology & Oncology · Modesto, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Banisadre from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Banisadre?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Banisadre
Dr. Mussa Banisadre is a hematology & oncology specialist in Modesto, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Banisadre performed 4,968 Medicare services across 618 unique beneficiaries.
Between the years covered by Open Payments, Dr. Banisadre received a total of $15,544 from 75 pharmaceutical and/or device companies across 673 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Banisadre is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in CA
$15,544 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,968
Medicare services
Top 33% in CA for hematology & oncology
618
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~261 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,874 | $0 | $17 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,020 | $1 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
542 | $96 | $391 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
248 | $24 | $88 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
215 | $13 | $51 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
198 | $110 | $403 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
197 | $12 | $46 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
110 | $17 | $62 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
100 | $1 | $30 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
91 | $24 | $84 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $68 | $276 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
69 | $54 | $185 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
68 | $54 | $190 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
54 | $4 | $32 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
40 | $20 | $89 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $142 | $542 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $135 | $484 |
| New patient office visit, complex (60-74 min) | 13 | $177 | $667 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $138 | $516 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.9% high complexity
71.5% medium
14.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,544
Total received (2018-2024)
Avg $2,221/year across 7 years
Top 26% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
673
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,162 (78.2%)
Other
Charitable contributions, space rental, and other categories
$2,491 (16.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$890 (5.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,659
2023
$2,283
2022
$2,178
2021
$2,968
2020
$1,045
2019
$1,941
2018
$2,471
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$590
Incyte Corporation
$321
ABBVIE INC.
$222
AstraZeneca Pharmaceuticals LP
$165
PFIZER INC.
$105
Merck Sharp & Dohme LLC
$100
Janssen Biotech, Inc.
$91
Celgene Corporation
$89
Astellas Pharma US Inc
$79
Daiichi Sankyo Inc.
$67
Genentech USA, Inc.
$65
E.R. Squibb & Sons, L.L.C.
$63
Stemline Therapeutics Inc.
$60
Ipsen Biopharmaceuticals, Inc
$56
Regeneron Healthcare Solutions, Inc.
$54
SpringWorks Therapeutics, Inc.
$53
GlaxoSmithKline, LLC.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Pharmacosmos Therapeutics Inc.
$42
GENZYME CORPORATION
$41
ARRAY BIOPHARMA INC
$41
Eisai Inc.
$41
Deciphera Pharmaceuticals Inc.
$35
SOBI, INC
$31
MorphoSys, US Inc.
$22
Aveo Pharmaceuticals, Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
SERVIER PHARMACEUTICALS LLC
$22
Azurity Pharmaceuticals, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Celltrion USA Inc.
$20
Mirati Therapeutics, Inc.
$17
Top 3 companies account for 42.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,861
PFIZER INC.
$1,116
AstraZeneca Pharmaceuticals LP
$925
E.R. Squibb & Sons, L.L.C.
$811
Amgen Inc.
$667
Janssen Biotech, Inc.
$495
Incyte Corporation
$478
Seagen Inc.
$428
Merck Sharp & Dohme Corporation
$417
Genentech USA, Inc.
$402
GlaxoSmithKline, LLC.
$356
Merck Sharp & Dohme LLC
$334
Celgene Corporation
$327
Kite Pharma, Inc.
$323
ABBVIE INC.
$306
Eisai Inc.
$288
GENZYME CORPORATION
$231
Takeda Pharmaceuticals U.S.A., Inc.
$224
Octapharma USA, Inc.
$215
NOVARTIS PHARMACEUTICALS CORPORATION
$209
Lilly USA, LLC
$194
Gilead Sciences, Inc.
$190
Astellas Pharma US Inc
$181
Daiichi Sankyo Inc.
$164
EISAI INC.
$161
Pharmacyclics LLC, An AbbVie Company
$146
Sirtex Medical Inc
$139
Boehringer Ingelheim Pharmaceuticals, Inc.
$135
ARRAY BIOPHARMA INC
$127
AVEO Pharmaceuticals, Inc.
$122
AbbVie, Inc.
$122
Regeneron Healthcare Solutions, Inc.
$121
Ipsen Biopharmaceuticals, Inc
$118
Kyowa Kirin, Inc.
$112
EMD Serono, Inc.
$111
Stemline Therapeutics Inc.
$103
Pharmacosmos Therapeutics Inc.
$100
SANOFI-AVENTIS U.S. LLC
$100
Mirati Therapeutics, Inc.
$95
Exelixis Inc.
$93
MorphoSys, US Inc.
$93
Rigel Pharmaceuticals, Inc.
$84
Sobi, Inc
$80
Teva Pharmaceuticals USA, Inc.
$79
Taiho Oncology, Inc.
$69
Epizyme, Inc.,
$69
Pharmacyclics LLC, an AbbVie Company
$68
Aveo Pharmaceuticals, Inc.
$67
Clovis Oncology, Inc.
$63
TESARO, Inc.
$62
Mylan Institutional Inc.
$54
Deciphera Pharmaceuticals Inc.
$54
SpringWorks Therapeutics, Inc.
$53
Dova Pharmaceuticals
$44
Puma Biotechnology, Inc.
$43
SERVIER PHARMACEUTICALS LLC
$41
AbbVie Inc.
$41
Flowonix Medical Incorporated
$40
Agios Pharmaceuticals, Inc.
$33
Jazz Pharmaceuticals Inc.
$32
SOBI, INC
$31
Janssen Pharmaceuticals, Inc
$29
BeiGene USA, Inc.
$29
TAIHO ONCOLOGY, INC.
$26
PharmaEssentia USA Corporation
$22
Amneal Pharmaceuticals LLC
$22
Azurity Pharmaceuticals, Inc.
$21
Foundation Medicine, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Celltrion USA Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
JAZZ PHARMACEUTICALS INC.
$18
Seattle Genetics, Inc.
$18
AMAG Pharmaceuticals, Inc.
$16
Acrotech Biopharma LLC
$14
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
Alecensa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · DAURISMO · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erleada · FARESTON · FASLODEX · FERAHEME · FOTIVDA · Fabhalta · Fulphila · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idhifa · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NEUPOGEN · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · ONUREG · OPDIVO · Onivyde · Orserdu · PADCEV · PANZYGA · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · Prometra II · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · VEGZELMA · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · VPRIV · VYXEOS · Venclexta · WILATE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XTANDI · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
9
Per 100K population
1.6
County median income
$79,661
Nearest hospital
DOCTORS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Banisadre is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Banisadre experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Banisadre performed 1,874 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Banisadre receive payments from pharmaceutical companies?
Yes. Dr. Banisadre received a total of $15,544 from 75 companies across 673 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Banisadre's costs compare to other hematology & oncology specialists in Modesto?
Dr. Banisadre's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Banisadre) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Modesto
Browse hematology & oncology specialists in Modesto ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology